Logo image of JOAN

JOANN INC (JOAN) Stock Fundamental Analysis

USA - NASDAQ:JOAN - US47768J1016 - Common Stock

0.0969 USD
-0.01 (-11.91%)
Last: 3/27/2024, 8:23:15 PM
0.0893 USD
-0.01 (-7.84%)
After Hours: 3/27/2024, 8:23:15 PM
Fundamental Rating

1

Taking everything into account, JOAN scores 1 out of 10 in our fundamental rating. JOAN was compared to 119 industry peers in the Specialty Retail industry. Both the profitability and financial health of JOAN have multiple concerns. JOAN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

JOAN had negative earnings in the past year.
In the past year JOAN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: JOAN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: JOAN reported negative operating cash flow in multiple years.
JOAN Yearly Net Income VS EBIT VS OCF VS FCFJOAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.64%, JOAN is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
ROA -10.64%
ROE N/A
ROIC N/A
ROA(3y)0.76%
ROA(5y)-3.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JOAN Yearly ROA, ROE, ROICJOAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 100 200 300 400 500

1.3 Margins

With a decent Gross Margin value of 49.29%, JOAN is doing good in the industry, outperforming 76.98% of the companies in the same industry.
In the last couple of years the Gross Margin of JOAN has declined.
The Profit Margin and Operating Margin are not available for JOAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.64%
GM growth 5Y-1.71%
JOAN Yearly Profit, Operating, Gross MarginsJOAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40

1

2. Health

2.1 Basic Checks

JOAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
JOAN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, JOAN has a worse debt to assets ratio.
JOAN Yearly Shares OutstandingJOAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M
JOAN Yearly Total Debt VS Total AssetsJOAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

JOAN has an Altman-Z score of 0.69. This is a bad value and indicates that JOAN is not financially healthy and even has some risk of bankruptcy.
JOAN has a worse Altman-Z score (0.69) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACCN/A
WACC5.55%
JOAN Yearly LT Debt VS Equity VS FCFJOAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.43 indicates that JOAN should not have too much problems paying its short term obligations.
JOAN has a Current ratio of 1.43. This is comparable to the rest of the industry: JOAN outperforms 47.62% of its industry peers.
JOAN has a Quick Ratio of 1.43. This is a bad value and indicates that JOAN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of JOAN (0.20) is worse than 84.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.2
JOAN Yearly Current Assets VS Current LiabilitesJOAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M

2

3. Growth

3.1 Past

The earnings per share for JOAN have decreased strongly by -1104.00% in the last year.
JOAN shows a decrease in Revenue. In the last year, the revenue decreased by -4.20%.
Measured over the past years, JOAN shows a decrease in Revenue. The Revenue has been decreasing by -0.86% on average per year.
EPS 1Y (TTM)-1104%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-450%
Revenue 1Y (TTM)-4.2%
Revenue growth 3Y-0.36%
Revenue growth 5Y-0.86%
Sales Q2Q%-4.09%

3.2 Future

JOAN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.34% yearly.
The Revenue is expected to grow by 0.04% on average over the next years.
EPS Next Y-170.79%
EPS Next 2Y-41.33%
EPS Next 3Y0.34%
EPS Next 5Y9.34%
Revenue Next Year-1.07%
Revenue Next 2Y-1.21%
Revenue Next 3Y-0.6%
Revenue Next 5Y0.04%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JOAN Yearly Revenue VS EstimatesJOAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
JOAN Yearly EPS VS EstimatesJOAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

0

4. Valuation

4.1 Price/Earnings Ratio

JOAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year JOAN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JOAN Price Earnings VS Forward Price EarningsJOAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JOAN Per share dataJOAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.33%
EPS Next 3Y0.34%

0

5. Dividend

5.1 Amount

No dividends for JOAN!.
Industry RankSector Rank
Dividend Yield N/A

JOANN INC

NASDAQ:JOAN (3/27/2024, 8:23:15 PM)

After market: 0.0893 -0.01 (-7.84%)

0.0969

-0.01 (-11.91%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-28 2024-03-28/amc
Earnings (Next)06-03 2024-06-03/amc
Inst Owners0.13%
Inst Owner Change-29.15%
Ins Owners5.98%
Ins Owner Change0%
Market Cap4.06M
Analysts47.5
Price Target1.53 (1478.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.33
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.38%
Min EPS beat(2)-22.55%
Max EPS beat(2)3.79%
EPS beat(4)1
Avg EPS beat(4)-36.87%
Min EPS beat(4)-90.17%
Max EPS beat(4)3.79%
EPS beat(8)2
Avg EPS beat(8)-67.61%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)1.71%
Revenue beat(4)1
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)1.71%
Revenue beat(8)2
Avg Revenue beat(8)-2.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)50%
PT rev (3m)41.18%
EPS NQ rev (1m)-35.51%
EPS NQ rev (3m)-47.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.24%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)1.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.51
EYN/A
EPS(NY)-1.68
Fwd EYN/A
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS51.65
BVpS-4.37
TBVpS-14.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.29%
FCFM N/A
ROA(3y)0.76%
ROA(5y)-3.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.64%
GM growth 5Y-1.71%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 64.07%
Cap/Sales 2.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.2
Altman-Z 0.69
F-Score3
WACC5.55%
ROIC/WACCN/A
Cap/Depr(3y)79.77%
Cap/Depr(5y)80.88%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1104%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-450%
EPS Next Y-170.79%
EPS Next 2Y-41.33%
EPS Next 3Y0.34%
EPS Next 5Y9.34%
Revenue 1Y (TTM)-4.2%
Revenue growth 3Y-0.36%
Revenue growth 5Y-0.86%
Sales Q2Q%-4.09%
Revenue Next Year-1.07%
Revenue Next 2Y-1.21%
Revenue Next 3Y-0.6%
Revenue Next 5Y0.04%
EBIT growth 1Y-29.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year138.21%
EBIT Next 3Y47.29%
EBIT Next 5Y31.02%
FCF growth 1Y-223.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-396.61%
OCF growth 3YN/A
OCF growth 5YN/A